Assuntos
COVID-19 , Mucormicose , Humanos , Mucor , Mucormicose/diagnóstico , Mucormicose/prevenção & controle , SARS-CoV-2Assuntos
Tuberculose Miliar/complicações , Tuberculose Miliar/diagnóstico por imagem , Tuberculose Ocular/diagnóstico por imagem , Adolescente , Antituberculosos/uso terapêutico , Feminino , Humanos , Mycobacterium tuberculosis/isolamento & purificação , Tomografia Computadorizada por Raios X , Teste Tuberculínico , Tuberculose Miliar/tratamento farmacológico , Tuberculose Ocular/complicações , Tuberculose Ocular/tratamento farmacológicoRESUMO
Dear Editor, A 17-year-old boy, diagnosed with Systemic Lupus Erythematosus (SLE), presented to ophthalmology department with gradual painless diminution of vision in both eyes (right more than left). He had already received 6 pulses of cyclophosphamide and steroids at monthly intervals one year back for diffuse alveolar hemorrhage (DAH) and was on maintenance oral 40 mg prednisolone and 3 grams mycophenolate mofetil (MMF). There was no history of oliguria, skin rash, joint pain, oral ulcers, photosensitivity or any neurological deficit in this presentation. There was no proteinuria, hematuria or worsening of renal function.
Assuntos
Pneumopatias/patologia , Lúpus Eritematoso Sistêmico/diagnóstico , Vasculite Retiniana/diagnóstico por imagem , Transtornos da Visão/etiologia , Adolescente , Angiofluoresceinografia/métodos , Fundo de Olho , Hemorragia/diagnóstico , Hemorragia/etiologia , Humanos , Fatores Imunológicos/administração & dosagem , Fatores Imunológicos/uso terapêutico , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Masculino , Recidiva , Vasculite Retiniana/tratamento farmacológico , Vasculite Retiniana/etiologia , Retinite/diagnóstico , Rituximab/administração & dosagem , Rituximab/uso terapêutico , Resultado do Tratamento , Transtornos da Visão/diagnóstico , Acuidade Visual/efeitos dos fármacosRESUMO
Due to the nature of their profession, health care personnel (HCP) have always been easy targets for transmission of communicable diseases like COVID-19. Shielding HCPs is of consequential significance in ensuring continued health care for the whole population in addition to reducing further spread. Close contact, repeated contact and prolonged contact are unavoidable in the intensive care (IC) environment. It is not uncommon for IC-HCPs to get carried away during an emergent situation, such as that posed by a suddenly deteriorating patient, and forgo the protective barriers that protect them from contracting a communicable infection. Some notable precautionary measures are mentioned below. This is by no means an exhaustive list.
Assuntos
Betacoronavirus , Infecções por Coronavirus , Pessoal de Saúde , Controle de Infecções/métodos , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Pandemias , Pneumonia Viral , COVID-19 , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/transmissão , Cuidados Críticos , Desinfecção , Desinfecção das Mãos , Humanos , Higiene , Pandemias/prevenção & controle , Pneumonia Viral/prevenção & controle , Pneumonia Viral/transmissão , Roupa de Proteção , SARS-CoV-2RESUMO
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder. Here, we present a rare case of a middle-aged male, diagnosed with SLE, manifesting as bilateral central retinal artery occlusion (CRAO). Severe ocular complications such as CRAO may occur during an acute flare or even early in the disease process. It is important to recognize this potentially devastating complication.
